SHL Telemedicine Appoints New CEO
Ticker: SHMLF · Form: 6-K · Filed: Jul 29, 2024 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | Jul 29, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, ceo-appointment
TL;DR
SHL Telemedicine gets a new CEO, David Arnon, starting Aug 6.
AI Summary
SHL Telemedicine Ltd. announced on July 29, 2024, the appointment of David Arnon as its new Chief Executive Officer, effective August 6, 2024. This follows a previous disclosure on March 14, 2024, regarding changes in leadership.
Why It Matters
A change in CEO can signal a shift in company strategy or operational focus, potentially impacting future performance and investor outlook.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a leadership change and does not contain significant financial or operational risks.
Key Players & Entities
- SHL Telemedicine Ltd. (company) — The company making the announcement.
- David Arnon (person) — Appointed as the new Chief Executive Officer.
- August 6, 2024 (date) — Effective date for the new CEO.
- July 29, 2024 (date) — Date of the press release announcing the CEO change.
- March 14, 2024 (date) — Date of a previous filing related to leadership changes.
FAQ
Who has been appointed as the new CEO of SHL Telemedicine Ltd.?
David Arnon has been appointed as the new Chief Executive Officer of SHL Telemedicine Ltd.
When is David Arnon's appointment as CEO effective?
David Arnon's appointment as CEO is effective August 6, 2024.
What type of filing is this report?
This report is a Form 6-K, a Report of Foreign Private Issuer.
What was the date of the press release announcing the CEO change?
The press release announcing the CEO change was issued on July 29, 2024.
Does SHL Telemedicine Ltd. file annual reports under Form 20-F or 40-F?
SHL Telemedicine Ltd. files annual reports under Form 20-F.
Filing Stats: 267 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-07-29 06:01:01
Filing Documents
- zk2431718.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 9KB
- image00001.jpg (GRAPHIC) — 14KB
- image00002.jpg (GRAPHIC) — 10KB
- 0001178913-24-002299.txt ( ) — 54KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-41641 SHL TELEMEDICINE LTD. (Translation of registrant's name into English) 90 Yigal Alon Street Tel Aviv 67891, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXPLANATORY NOTE On July 29, 2024, SHL Telemedicine Ltd. (the " Company ") issued a press release, a copy of which is furnished herewith as Exhibit 99.1. In the press release, the Company announced that it has appointed David Arnon to serve as the Company's new Chief Executive Officer, effective August 6, 2024. As previously disclosed in the Company's Form 6-K filed with the Securities and Exchange Commission on March 14, 2024, Erez Nachtomy, the Company's current CEO, announced his resignation, which will be effective upon Mr. Arnon assuming the position of CEO. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546) . Exhibit Description 99.1 Press release, dated July 29, 2024, issued by the Company. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL Telemedicine Ltd. By: /s/ Amir Hai Amir Hai Chief Financial Officer July 29, 2024